Dashboard
Manage Tickers

KTTAPasithea Therapeutics Corp.

Nasdaq pasithea.com


$ 4.29 $ 0.37 (9.44 %)    

Tuesday, 17-Sep-2024 15:41:01 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.89 $ -2.08 (-0.44 %)
DIA $ 417.12 $ -0.26 (-0.06 %)
SPY $ 563.14 $ 0.30 (0.05 %)
TLT $ 100.82 $ -0.51 (-0.5 %)
GLD $ 237.35 $ -1.31 (-0.55 %)
$ 3.92
$ 4.08
-- x --
-- x --
$ 4.08 - $ 4.49
$ 3.61 - $ 17.40
2,062
na
4.09M
$ 0.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-18-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pasithea-therapeutics-announces-the-completion-of-long-term-chronic-toxicity-studies-in-both-rats-and-dogs-with-its-lead-candidate-pas-004-currently-being-investigated-in-a-phase-1-clinical-trial-in-advanced-cancer-patients
Pasithea Therapeutics Announces The Comple...
09/09/2024 12:20:23

Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company...

pasithea-therapeutics-announces-an-independent-safety-review-committee-completes-safety-review-of-data-from-first-dose-cohort-in-phase-1-trial-of-pas-004
Pasithea Therapeutics Announces An Indepen...
06/13/2024 11:07:30

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 16:31:07

pasithea-therapeutics-to-present-new-preclinical-data-showing-pas-004-strongly-inhibiting-nras-cancer-cell-lines
Pasithea Therapeutics To Present New Precl...
05/28/2024 11:01:12

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/17/2024 16:31:07

pasithea-therapeutics-announces-pas-004-abstract-accepted-for-poster-presentation-at-2024-asco-annual-meeting
Pasithea Therapeutics Announces PAS-004 Ab...
04/29/2024 12:14:23

Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company...

pasithea-therapeutics-announces-the-first-cohort-has-completed-the-initial-dosing-in-its-phase-1-trial-evaluating-pas-004-in-ras-nf1-and-raf-mutated-cancers
Pasithea Therapeutics Announces The First ...
04/24/2024 12:05:41

Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company...

pasithea-therapeutics-announces-opening-of-enrollment-in-the-us-for-its-phase-1-trial-of-pas-004
Pasithea Therapeutics Announces Opening Of...
02/13/2024 12:59:55

-- Activation of four U.S. sites for Phase 1 clinical trial of PAS-004 to evaluate safety, dose, key biomarker data and prelimi...

pasithea-therapeutics-announces-invention-of-crystalline-form-of-pas-004-establishes-strengthened-intellectual-property-position
Pasithea Therapeutics Announces Invention ...
01/08/2024 13:00:09

-- Polymorph and Stereoisomer Patents when Issued Extend Portfolio to at least 2045 -- -- Polymorph and Stereoisomer Patent Fil...

pasithea-therapeutics-shares-resume-trade
Pasithea Therapeutics Shares Resume Trade
01/02/2024 14:00:37

pasithea-therapeutics-announces-fda-acceptance-of-ind-application-to-evaluate-pas-004-in-advanced-cancer-patients
Pasithea Therapeutics Announces FDA Accept...
01/02/2024 13:39:01

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
12/30/2023 00:50:04

pasithea-therapeutics-corp-announces-1-for-20-reverse-stock-split-anticipates-common-stock-will-begin-trading-on-a-reverse-stock-split-adjusted-basis-at-market-open-on-january-2-2024
Pasithea Therapeutics Corp Announces 1-For...
12/28/2023 16:41:40

- SEC Filing On December 28, 2023, Pasithea Therapeutics Corp. (the "Company") filed a Certificate of Amendment to the ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/25/2023 17:30:49

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 13:07:41

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/13/2023 13:07:30

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/12/2023 13:07:33

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
12/11/2023 21:31:07

nasdaq-edges-higher-macys-shares-jump
Nasdaq Edges Higher; Macy's Shares Jump
12/11/2023 19:26:20

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Monday. The Dow tra...

why-bluebird-bio-shares-are-trading-higher-here-are-other-stocks-moving-in-mondays-mid-day-session
Why bluebird bio Shares Are Trading Higher...
12/11/2023 18:12:59

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION